42
Growth Score
pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
404561
Celleron Therapeutics is an oncology company dedicated to funding new and innovative treatments for cancer.
Acquired by 
IngenOx Therapeutics
- Declan Doogan: ChairmanPast Role: Prometheus Biosciences, Eexecutive VP and CMO
John Whittaker: Chief Operating OfficerPast Role: Kendle International, UK General Manager
About the Company
Celleron Therapeutics An innovative oncology healthcare company The future of cancer therapy lies in the ability to match patients to treatments they will respond favourably to. Celleron has developed biomarkers using epigenetic techniques that match drugs to responsive disease. Their portfolio of technologies can be used to develop a new class of
mechanism-based cancer drugs. Drugs that will improve the success rates of treatment, reduce the side effects in patients and deliver more cost effective healthcare.
